NineBiopharm Co.
Latest round
- Series A
Last raised
- Dec 2021
Total raised
- $6.7M
Investors
- 6
About NineBiopharm Co.
,Ltd.,Ltd. operates primarily in the streaming industry, delivering video content to a global audience. The company was co-founded by HASSAN SADALI, Maxine Anderson, Michael Ioffe, and Ryan Laverty, with Michael Ioffe currently serving as CEO.,Ltd. offers a range of streaming video content that includes high-definition live streams, replays, and adult-themed videos. The platform caters to a diverse audience, allowing users to access a wide variety of sports highlights and adult entertainment. Their services are available globally, with a particular emphasis on markets in Asia, where demand for such content is significant.The company primarily generates revenue through subscription models, which allow users to access its broad range of video content. Clients subscribe to different plans tailored to their content preferences, enabling them to stream both adult and sports videos.,Ltd. plans to expand its offerings and reach into new markets. The funds will be allocated towards developing upcoming new products and enhancing the technology behind their streaming services. The company aims to target additional markets in Asia and potentially other regions where demand for adult content and sports broadcasting is growing. Specific launch dates for the new products have yet to be announced.
Who invested in NineBiopharm Co.
6 investors across 1 round
See all investors in NineBiopharm Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 20, 2021
Amount
$6.7M
Investors
Questions about NineBiopharm Co.
Who invested in NineBiopharm Co.?
NineBiopharm Co. has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NineBiopharm Co. raised?
NineBiopharm Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did NineBiopharm Co. last raise money?
NineBiopharm Co.'s most recent round on record is a Series A, in Dec 2021.
What does NineBiopharm Co. do?
NineBiopharm Co. is a biotechnology company.
Where is NineBiopharm Co. headquartered?
NineBiopharm Co. is headquartered in Cheongju, South Korea.
Which VCs invest in companies like NineBiopharm Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at NineBiopharm Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like NineBiopharm Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.